Showing results (421-430 of 5,984) with videos related to

Sort By:
Pageof 599
Molecular Cancer Therapeutics|December 20, 2002
Peroxisome proliferator-activated receptor modulators as potential chemopreventive agentsLevy Kopelovich, Judith R Fay, Robert I Glazer, et al.
Molecular Cancer Therapeutics|December 21, 2002
The antiangiogenic agent Neovastat (AE-941) induces endothelial cell apoptosisDominique Boivin, Sébastien Gendron, Edith Beaulieu, et al.
Molecular Cancer Therapeutics|December 21, 2002
Mifepristone pretreatment overcomes resistance of prostate cancer cells to tumor necrosis factor alpha-related apoptosis-inducing ligand (TRAIL)Manal A Eid, Ronald W Lewis, M Vijay Kumar
Molecular Cancer Therapeutics|December 21, 2002
PS-341, a novel proteasome inhibitor, induces Bcl-2 phosphorylation and cleavage in association with G2-M phase arrest and apoptosisYi-He Ling, Leonard Liebes, Bruce Ng, et al.
Molecular Cancer Therapeutics|December 21, 2002
Regulation of p53 stabilization by DNA damage and protein kinase CCassie L Johnson, Dongmei Lu, Jie Huang, et al.
Molecular Cancer Therapeutics|December 17, 2002
The antisignaling agent SC-alpha alpha delta 9, 4-(benzyl-(2-[(2,5-diphenyloxazole-4-carbonyl)amino]ethyl)carbamoyl)- 2-decanoylaminobutyric acid, is a structurally unique phospholipid analogue with phospholipase C inhibitory activityAndreas Vogt, Katharine E Pestell, Billy W Day, et al.
Molecular Cancer Therapeutics|December 17, 2002
Combination therapy with AG-490 and interleukin 12 achieves greater antitumor effects than either agent aloneLyudmila Burdelya, Robyn Catlett-Falcone, Alexander Levitzki, et al.
Molecular Cancer Therapeutics|December 17, 2002
Inhibition of phosphatidylinositol 3-kinase-Akt signaling blocks growth, promotes apoptosis, and enhances sensitivity of small cell lung cancer cells to chemotherapyGeoffrey W Krystal, Geoffrey Sulanke, Julie Litz
Molecular Cancer Therapeutics|December 17, 2002
O6-benzylguanine-mediated enhancement of chemotherapyHenry S Friedman, Stephen Keir, Anthony E Pegg, et al.
Molecular Cancer Therapeutics|December 17, 2002
Intratumoral injection of interleukin-12 plasmid DNA, either naked or in complex with cationic lipid, results in similar tumor regression in a murine modelFushun Shi, Alexander L Rakhmilevich, Chuck P Heise, et al.
Pageof 599